Advertisement

The Journal of Physiological Sciences

, Volume 69, Issue 2, pp 175–184 | Cite as

Epac1 deficiency inhibits basic fibroblast growth factor-mediated vascular smooth muscle cell migration

  • Yuko Kato
  • Utako YokoyamaEmail author
  • Takayuki Fujita
  • Masanari Umemura
  • Tetsuo Kubota
  • Yoshihiro IshikawaEmail author
Original Paper
  • 119 Downloads

Abstract

Vascular smooth muscle cell (VSMC) migration and the subsequent intimal thickening play roles in vascular restenosis. We previously reported that an exchange protein activated by cAMP 1 (Epac1) promotes platelet-derived growth factor (PDGF)-induced VSMC migration and intimal thickening. Because basic fibroblast growth factor (bFGF) also plays a pivotal role in restenosis, we examined whether Epac1 was involved in bFGF-mediated VSMC migration. bFGF-induced lamellipodia formation and migration were significantly decreased in VSMCs obtained from Epac1−/− mice compared to those in Epac1+/+-VSMCs. The bFGF-induced phosphorylation of Akt and glycogen synthase kinase 3β (GSK3β), which play a role in bFGF-induced cell migration, was attenuated in Epac1−/−-VSMCs. Intimal thickening induced by the insertion of a large wire was attenuated in Epac1−/− mice, and was accompanied by the decreased phosphorylation of GSK3β. These data suggest that Epac1 deficiency attenuates bFGF-induced VSMC migration, possibly via Akt/GSK3β pathways.

Keywords

Exchange protein activated by cAMP 1 Intimal thickening Basic fibroblast growth factor Vascular smooth muscle cells Migration 

Notes

Acknowledgements

The authors are grateful to Yuka Sawada (Yokohama City University) for histological analysis.

Funding sources

This study was funded by MEXT/JSPS KAKENHI (YK, JP17K08976; UY, JP17K19403, JP16H05358, JP15H05761; YI, JPH1605300), the Takeda Science Foundation (YK), the Japan Agency for Medical Research and Development (AMED) (YI, 66890007, 66891153), and the Kitsuen Research Foundation (YI, 71890005).

Supplementary material

Supplemental movie I. Epac1+/+-VSMC migration under stimulation with 10 ng/ml of bFGF. (MPG 887 kb)

Supplemental movie II. Epac1−/−-VSMC migration under stimulation with 10 ng/ml of bFGF. (MPG 885 kb)

References

  1. 1.
    Schwartz SM (1997) Perspectives series: cell adhesion in vascular biology. Smooth muscle migration in atherosclerosis and restenosis. J Clin Investig 99:2814–2816CrossRefGoogle Scholar
  2. 2.
    Newby AC, Zaltsman AB (2000) Molecular mechanisms in intimal hyperplasia. J Pathol 190:300–309CrossRefGoogle Scholar
  3. 3.
    Stolker JM, Kennedy KF, Lindsey JB, Marso SP, Pencina MJ, Cutlip DE, Mauri L, Kleiman NS, Cohen DJ, Investigators E (2010) Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry. Circ Cardiovasc Interv 3:327–334CrossRefGoogle Scholar
  4. 4.
    Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, Gold HK, Virmani R (2007) Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115:2435–2441CrossRefGoogle Scholar
  5. 5.
    Casscells W (1992) Migration of smooth muscle and endothelial cells. Critical events in restenosis. Circulation 86:723–729CrossRefGoogle Scholar
  6. 6.
    Jackson CL, Reidy MA (1993) Basic fibroblast growth factor: its role in the control of smooth muscle cell migration. Am J Pathol 143:1024–1031Google Scholar
  7. 7.
    Schroder K, Helmcke I, Palfi K, Krause KH, Busse R, Brandes RP (2007) Nox1 mediates basic fibroblast growth factor-induced migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 27:1736–1743CrossRefGoogle Scholar
  8. 8.
    Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA (1991) Role of basic fibroblast growth factor in vascular lesion formation. Circ Res 68:106–113CrossRefGoogle Scholar
  9. 9.
    Lindner V (1995) Role of basic fibroblast growth factor and platelet-derived growth factor (B-chain) in neointima formation after arterial injury. Z Kardiol 84(Suppl 4):137–144Google Scholar
  10. 10.
    Yokoyama U, Minamisawa S, Quan H, Akaike T, Jin M, Otsu K, Ulucan C, Wang X, Baljinnyam E, Takaoka M, Sata M, Ishikawa Y (2008) Epac1 is upregulated during neointima formation and promotes vascular smooth muscle cell migration. Am J Physiol Heart Circ Physiol 295:H1547–H1555CrossRefGoogle Scholar
  11. 11.
    Yokoyama U, Minamisawa S, Quan H, Akaike T, Suzuki S, Jin M, Jiao Q, Watanabe M, Otsu K, Iwasaki S, Nishimaki S, Sato M, Ishikawa Y (2008) Prostaglandin E2-activated Epac promotes neointimal formation of the rat ductus arteriosus by a process distinct from that of cAMP-dependent protein kinase A. J Biol Chem 283:28702–28709CrossRefGoogle Scholar
  12. 12.
    Yokoyama U, Patel HH, Lai NC, Aroonsakool N, Roth DM, Insel PA (2008) The cyclic AMP effector Epac integrates pro- and anti-fibrotic signals. Proc Natl Acad Sci USA 105:6386–6391CrossRefGoogle Scholar
  13. 13.
    Kato Y, Yokoyama U, Yanai C, Ishige R, Kurotaki D, Umemura M, Fujita T, Kubota T, Okumura S, Sata M, Tamura T, Ishikawa Y (2015) Epac1 deficiency attenuated vascular smooth muscle cell migration and neointimal formation. Arterioscler Thromb Vasc Biol 35:2617–2625CrossRefGoogle Scholar
  14. 14.
    Wang H, Robichaux WG, Wang Z, Mei FC, Cai M, Du G, Chen J, Cheng X (2016) Inhibition of Epac1 suppresses mitochondrial fission and reduces neointima formation induced by vascular injury. Sci Rep 6:36552CrossRefGoogle Scholar
  15. 15.
    Wang X, Zhu Y, Sun C, Wang T, Shen Y, Cai W, Sun J, Chi L, Wang H, Song N, Niu C, Shen J, Cong W, Zhu Z, Xuan Y, Li X, Jin L (2017) Feedback activation of basic fibroblast growth factor signaling via the Wnt/beta-catenin pathway in skin fibroblasts. Front Pharmacol 8:32Google Scholar
  16. 16.
    Schmidt A, Ladage D, Schinkothe T, Klausmann U, Ulrichs C, Klinz FJ, Brixius K, Arnhold S, Desai B, Mehlhorn U, Schwinger RH, Staib P, Addicks K, Bloch W (2006) Basic fibroblast growth factor controls migration in human mesenchymal stem cells. Stem Cells 24:1750–1758CrossRefGoogle Scholar
  17. 17.
    Shi H, Lin B, Huang Y, Wu J, Zhang H, Lin C, Wang Z, Zhu J, Zhao Y, Fu X, Lou Z, Li X, Xiao J (2016) Basic fibroblast growth factor promotes melanocyte migration via activating PI3 K/Akt-Rac1-FAK-JNK and ERK signaling pathways. IUBMB Life 68:735–747CrossRefGoogle Scholar
  18. 18.
    Shimabukuro Y, Terashima H, Takedachi M, Maeda K, Nakamura T, Sawada K, Kobashi M, Awata T, Oohara H, Kawahara T, Iwayama T, Hashikawa T, Yanagita M, Yamada S, Murakami S (2011) Fibroblast growth factor-2 stimulates directed migration of periodontal ligament cells via PI3 K/AKT signaling and CD44/hyaluronan interaction. J Cell Physiol 226:809–821CrossRefGoogle Scholar
  19. 19.
    Shigematsu K, Koyama H, Olson NE, Cho A, Reidy MA (2000) Phosphatidylinositol 3-kinase signaling is important for smooth muscle cell replication after arterial injury. Arterioscler Thromb Vasc Biol 20:2373–2378CrossRefGoogle Scholar
  20. 20.
    Jing H, Yen JH, Ganea D (2004) A novel signaling pathway mediates the inhibition of CCL3/4 expression by prostaglandin E2. J Biol Chem 279:55176–55186CrossRefGoogle Scholar
  21. 21.
    Namkoong S, Kim CK, Cho YL, Kim JH, Lee H, Ha KS, Choe J, Kim PH, Won MH, Kwon YG, Shim EB, Kim YM (2009) Forskolin increases angiogenesis through the coordinated cross-talk of PKA-dependent VEGF expression and Epac-mediated PI3 K/Akt/eNOS signaling. Cell Signal 21:906–915CrossRefGoogle Scholar
  22. 22.
    Villarreal F, Epperson SA, Ramirez-Sanchez I, Yamazaki KG, Brunton LL (2009) Regulation of cardiac fibroblast collagen synthesis by adenosine: roles for Epac and PI3 K. Am J Physiol Cell Physiol 296:C1178–C1184CrossRefGoogle Scholar
  23. 23.
    Baviera AM, Zanon NM, Navegantes LC, Kettelhut IC (2010) Involvement of cAMP/Epac/PI3K-dependent pathway in the antiproteolytic effect of epinephrine on rat skeletal muscle. Mol Cell Endocrinol 315:104–112CrossRefGoogle Scholar
  24. 24.
    Suzuki S, Yokoyama U, Abe T, Kiyonari H, Yamashita N, Kato Y, Kurotani R, Sato M, Okumura S, Ishikawa Y (2010) Differential roles of Epac in regulating cell death in neuronal and myocardial cells. J Biol Chem 285:24248–24259CrossRefGoogle Scholar
  25. 25.
    Rauch BH, Millette E, Kenagy RD, Daum G, Fischer JW, Clowes AW (2005) Syndecan-4 is required for thrombin-induced migration and proliferation in human vascular smooth muscle cells. J Biol Chem 280:17507–17511CrossRefGoogle Scholar
  26. 26.
    Ghosh M, Song X, Mouneimne G, Sidani M, Lawrence DS, Condeelis JS (2004) Cofilin promotes actin polymerization and defines the direction of cell motility. Science 304:743–746CrossRefGoogle Scholar
  27. 27.
    Baljinnyam E, Iwatsubo K, Kurotani R, Wang X, Ulucan C, Iwatsubo M, Lagunoff D, Ishikawa Y (2009) Epac increases melanoma cell migration by a heparan sulfate-related mechanism. Am J Physiol Cell Physiol 297:C802–C813CrossRefGoogle Scholar
  28. 28.
    Liu ZC, Wang HS, Zhang G, Liu H, Chen XH, Zhang F, Chen DY, Cai SH, Du J (2014) AKT/GSK-3beta regulates stability and transcription of snail which is crucial for bFGF-induced epithelial-mesenchymal transition of prostate cancer cells. Biochim Biophys Acta 1840:3096–3105CrossRefGoogle Scholar
  29. 29.
    Cohen P, Frame S (2001) The renaissance of GSK3. Nat Rev Mol Cell Biol 2:769–776CrossRefGoogle Scholar
  30. 30.
    Pullen N, Thomas G (1997) The modular phosphorylation and activation of p70s6k. FEBS Lett 410:78–82CrossRefGoogle Scholar
  31. 31.
    Huang H, Tindall DJ (2007) Dynamic FoxO transcription factors. J Cell Sci 120:2479–2487CrossRefGoogle Scholar
  32. 32.
    Rutherford C, Martin W, Salame M, Carrier M, Anggard E, Ferns G (1997) Substantial inhibition of neo-intimal response to balloon injury in the rat carotid artery using a combination of antibodies to platelet-derived growth factor-BB and basic fibroblast growth factor. Atherosclerosis 130:45–51CrossRefGoogle Scholar
  33. 33.
    Hanna AK, Fox JC, Neschis DG, Safford SD, Swain JL, Golden MA (1997) Antisense basic fibroblast growth factor gene transfer reduces neointimal thickening after arterial injury. J Vasc Surg 25:320–325CrossRefGoogle Scholar
  34. 34.
    Baljinnyam E, Umemura M, Chuang C, De Lorenzo MS, Iwatsubo M, Chen S, Goydos JS, Ishikawa Y, Whitelock JM, Iwatsubo K (2014) Epac1 increases migration of endothelial cells and melanoma cells via FGF2-mediated paracrine signaling. Pigment Cell Melanoma Res 27:611–620CrossRefGoogle Scholar
  35. 35.
    de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, Bos JL (1998) Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396:474–477CrossRefGoogle Scholar
  36. 36.
    Gloerich M, Bos JL (2010) Epac: defining a new mechanism for cAMP action. Annu Rev Pharmacol Toxicol 50:355–375CrossRefGoogle Scholar
  37. 37.
    Soto I, Rosenthal JJ, Blagburn JM, Blanco RE (2006) Fibroblast growth factor 2 applied to the optic nerve after axotomy up-regulates BDNF and TrkB in ganglion cells by activating the ERK and PKA signaling pathways. J Neurochem 96:82–96CrossRefGoogle Scholar
  38. 38.
    Pursiheimo JP, Jalkanen M, Tasken K, Jaakkola P (2000) Involvement of protein kinase A in fibroblast growth factor-2-activated transcription. Proc Natl Acad Sci USA 97:168–173CrossRefGoogle Scholar
  39. 39.
    Yoshimata T, Yoneyama A, Jin-no Y, Tamai N, Kamiya Y (1999) Effects of dehydroepiandrosterone on mitogen-activated protein kinase in human aortic smooth muscle cells. Life Sci 65:431–440CrossRefGoogle Scholar
  40. 40.
    Logan A, Logan SD (1991) Studies on the mechanisms of signalling and inhibition by pertussis toxin of fibroblast growth factor-stimulated mitogenesis in Balb/c 3T3 cells. Cell Signal 3:215–223CrossRefGoogle Scholar
  41. 41.
    Jiang H, Guo W, Liang X, Rao Y (2005) Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3beta and its upstream regulators. Cell 120:123–135Google Scholar
  42. 42.
    Doble BW, Woodgett JR (2003) GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 116:1175–1186CrossRefGoogle Scholar
  43. 43.
    Etienne-Manneville S, Hall A (2003) Cdc42 regulates GSK-3beta and adenomatous polyposis coli to control cell polarity. Nature 421:753–756CrossRefGoogle Scholar
  44. 44.
    Park KW, Yang HM, Youn SW, Yang HJ, Chae IH, Oh BH, Lee MM, Park YB, Choi YS, Kim HS, Walsh K (2003) Constitutively active glycogen synthase kinase-3beta gene transfer sustains apoptosis, inhibits proliferation of vascular smooth muscle cells, and reduces neointima formation after balloon injury in rats. Arterioscler Thromb Vasc Biol 23:1364–1369CrossRefGoogle Scholar
  45. 45.
    Hall JL, Chatham JC, Eldar-Finkelman H, Gibbons GH (2001) Upregulation of glucose metabolism during intimal lesion formation is coupled to the inhibition of vascular smooth muscle cell apoptosis. Role of GSK3beta. Diabetes 50:1171–1179CrossRefGoogle Scholar
  46. 46.
    Jensen J, Brennesvik EO, Lai YC, Shepherd PR (2007) GSK-3beta regulation in skeletal muscles by adrenaline and insulin: evidence that PKA and PKB regulate different pools of GSK-3. Cell Signal 19:204–210CrossRefGoogle Scholar
  47. 47.
    Ster J, de Bock F, Bertaso F, Abitbol K, Daniel H, Bockaert J, Fagni L (2009) Epac mediates PACAP-dependent long-term depression in the hippocampus. J Physiol 587:101–113CrossRefGoogle Scholar
  48. 48.
    Liu J, Zhao X, Cao J, Xue Q, Feng X, Liu X, Zhang F, Yu B (2011) Differential roles of PKA and Epac on the production of cytokines in the endotoxin-stimulated primary cultured microglia. J Mol Neurosci MN 45:186–193CrossRefGoogle Scholar
  49. 49.
    Lee TM, Lin SZ, Chang NC (2013) Both PKA and Epac pathways mediate N-acetylcysteine-induced Connexin43 preservation in rats with myocardial infarction. PLoS One 8:e71878CrossRefGoogle Scholar
  50. 50.
    Sutherland C, Leighton IA, Cohen P (1993) Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J 296(Pt 1):15–19CrossRefGoogle Scholar
  51. 51.
    Cook D, Fry MJ, Hughes K, Sumathipala R, Woodgett JR, Dale TC (1996) Wingless inactivates glycogen synthase kinase-3 via an intracellular signalling pathway which involves a protein kinase C. EMBO J 15:4526–4536CrossRefGoogle Scholar
  52. 52.
    Gordon MD, Nusse R (2006) Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 281:22429–22433CrossRefGoogle Scholar
  53. 53.
    Riascos-Bernal DF, Chinnasamy P, Gross JN, Almonte V, Egana-Gorrono L, Parikh D, Jayakumar S, Guo L, Sibinga NES (2017) Inhibition of smooth muscle beta-catenin hinders neointima formation after vascular injury. Arterioscler Thromb Vasc Biol 37:879–888CrossRefGoogle Scholar
  54. 54.
    Manning BD, Cantley LC (2007) AKT/PKB signaling: navigating downstream. Cell 129:1261–1274CrossRefGoogle Scholar
  55. 55.
    Zhu LH, Huang L, Zhang X, Zhang P, Zhang SM, Guan H, Zhang Y, Zhu XY, Tian S, Deng K, Li H (2015) Mindin regulates vascular smooth muscle cell phenotype and prevents neointima formation. Clin Sci 129:129–145CrossRefGoogle Scholar
  56. 56.
    Wang Y, Bai Y, Qin L, Zhang P, Yi T, Teesdale SA, Zhao L, Pober JS, Tellides G (2007) Interferon-gamma induces human vascular smooth muscle cell proliferation and intimal expansion by phosphatidylinositol 3-kinase dependent mammalian target of rapamycin raptor complex 1 activation. Circ Res 101:560–569CrossRefGoogle Scholar

Copyright information

© The Physiological Society of Japan and Springer Japan KK, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Cardiovascular Research InstituteYokohama City UniversityYokohamaJapan
  2. 2.Department of ImmunopathologyTokyo Medical and Dental University, Graduate School of Medical and Dental SciencesTokyoJapan

Personalised recommendations